209 related articles for article (PubMed ID: 21151813)
21. Sensitization of skin mast cells with IgE antibodies to Culicoides allergens occurs frequently in clinically healthy horses.
Wagner B; Miller WH; Erb HN; Lunn DP; Antczak DF
Vet Immunol Immunopathol; 2009 Nov; 132(1):53-61. PubMed ID: 19836083
[TBL] [Abstract][Full Text] [Related]
22. IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking.
Strait RT; Morris SC; Finkelman FD
J Clin Invest; 2006 Mar; 116(3):833-41. PubMed ID: 16498503
[TBL] [Abstract][Full Text] [Related]
23. Allergen dose dependent cytokine production regulates specific IgE and IgG antibody production.
Blaser K
Adv Exp Med Biol; 1996; 409():295-303. PubMed ID: 9095257
[TBL] [Abstract][Full Text] [Related]
24. Internal images: human anti-idiotypic Fab antibodies mimic the IgE epitopes of grass pollen allergen Phl p 5a.
Hantusch B; Knittelfelder R; Wallmann J; Krieger S; Szalai K; Untersmayr E; Vogel M; Stadler BM; Scheiner O; Boltz-Nitulescu G; Jensen-Jarolim E
Mol Immunol; 2006 Jul; 43(14):2180-7. PubMed ID: 16510185
[TBL] [Abstract][Full Text] [Related]
25. Regulation of specific immune responses by chemical and structural modifications of allergens.
Akdis CA; Blaser K
Int Arch Allergy Immunol; 2000 Apr; 121(4):261-9. PubMed ID: 10828716
[TBL] [Abstract][Full Text] [Related]
26. Identification of anti-idiotypic antibodies in the sera of ryegrass-allergic and nonallergic individuals.
Valacer DJ; O'Reilly ME; Ilowite NT; Bonagura VR
J Allergy Clin Immunol; 1991 Sep; 88(3 Pt 1):349-55. PubMed ID: 1890262
[TBL] [Abstract][Full Text] [Related]
27. IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy.
van Neerven RJ; Knol EF; Ejrnaes A; Würtzen PA
Int Arch Allergy Immunol; 2006; 141(2):119-29. PubMed ID: 16864979
[TBL] [Abstract][Full Text] [Related]
28. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
[TBL] [Abstract][Full Text] [Related]
29. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
30.
Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
Front Immunol; 2020; 11():2118. PubMed ID: 33013894
[TBL] [Abstract][Full Text] [Related]
31. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
[TBL] [Abstract][Full Text] [Related]
32. Measurement of Allergen-Specific Inhibitory Antibody Activity.
Shamji MH; Francis JN
Methods Mol Biol; 2019; 2020():33-43. PubMed ID: 31177490
[TBL] [Abstract][Full Text] [Related]
33. Biopanning for the characterization of allergen mimotopes.
Pali-Schöll I; Jensen-Jarolim E
Methods Mol Med; 2008; 138():271-83. PubMed ID: 18612616
[TBL] [Abstract][Full Text] [Related]
34. Immunomodulatory activity of monoclonal anti-idiotypic antibody to anti-colorectal carcinoma antibody CO17-1A in animals and patients.
Herlyn D; Harris D; Zaloudik J; Sperlagh M; Maruyama H; Jacob L; Kieny MP; Scheck S; Somasundaram R; Hart E
J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):303-11. PubMed ID: 8061902
[TBL] [Abstract][Full Text] [Related]
35. IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization.
Uermösi C; Zabel F; Manolova V; Bauer M; Beerli RR; Senti G; Kündig TM; Saudan P; Bachmann MF
Allergy; 2014 Mar; 69(3):338-47. PubMed ID: 24354793
[TBL] [Abstract][Full Text] [Related]
36. Monovalent fusion proteins of IgE mimotopes are safe for therapy of type I allergy.
Ganglberger E; Barbara Sponer ; Schöll I; Wiedermann U; Baumann S; Hafner C; Breiteneder H; Suter M; Boltz-Nitulescu G; Scheiner O; Jensen-Jarolim E
FASEB J; 2001 Nov; 15(13):2524-6. PubMed ID: 11641259
[TBL] [Abstract][Full Text] [Related]
37. Allergen IgE-isotype-specific suppression by maternally derived monoclonal anti-IgG-idiotype.
Tanasa RI; Trad A; Lange H; Grötzinger J; Lemke H
Allergy; 2010 Jan; 65(1):16-23. PubMed ID: 19624555
[TBL] [Abstract][Full Text] [Related]
38. Regulation and targeting of T-cell immune responses by IgE and IgG antibodies.
Bheekha Escura R; Wasserbauer E; Hammerschmid F; Pearce A; Kidd P; Mudde GC
Immunology; 1995 Nov; 86(3):343-50. PubMed ID: 8550069
[TBL] [Abstract][Full Text] [Related]
39. Preclinical evaluation in nonhuman primates of murine monoclonal anti-idiotype antibody that mimics the disialoganglioside GD2.
Sen G; Chakraborty M; Foon KA; Reisfeld RA; Bhattacharya-Chatterjee M
Clin Cancer Res; 1997 Nov; 3(11):1969-76. PubMed ID: 9815586
[TBL] [Abstract][Full Text] [Related]
40. IgE epitope proximity determines immune complex shape and effector cell activation capacity.
Gieras A; Linhart B; Roux KH; Dutta M; Khodoun M; Zafred D; Cabauatan CR; Lupinek C; Weber M; Focke-Tejkl M; Keller W; Finkelman FD; Valenta R
J Allergy Clin Immunol; 2016 May; 137(5):1557-65. PubMed ID: 26684291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
